Siegfried Holding to acquire Noramco, Extractas Biosciences, and Purisys from SK Capital Partners.

Siegfried Holding, a pharmaceutical company that offers and manufactures primary and secondary drug substances and products, to acquire Noramco, Extractas Biosciences, and Purisys, pharmaceutical companies, from SK Capital Partners, a private investment firm. Financial terms were not disclosed. “SK Capital is privileged to have supported the Noramco Group and its team. We are excited to continue to support Halo Pharmaceuticals and accelerate its next phase of growth with greater focus as a standalone platform," Aaron Davenport, SK Capital Managing Director.